At close: 4:00:01 PM EST
After hours: 4:59:27 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
47.0000
103.0000
192.0000
268.0000
1,069.0000
Operating Expense
37,561.0000
52,251.0000
58,525.0000
56,991.0000
24,270.0000
Operating Income
-37,514.0000
-52,148.0000
-58,333.0000
-56,723.0000
-23,201.0000
Net Non Operating Interest Income Expense
12.0000
84.0000
160.0000
53.0000
120.0000
Other Income Expense
-8,966.0000
217.0000
-4,451.0000
--
--
Pretax Income
-46,468.0000
-51,847.0000
-62,624.0000
-56,670.0000
-23,081.0000
Net Income Common Stockholders
-46,468.0000
-51,847.0000
-62,624.0000
-56,670.0000
-23,081.0000
Diluted NI Available to Com Stockholders
-46,468.0000
-51,847.0000
-62,624.0000
-56,670.0000
-23,081.0000
Basic EPS
-1.83
-3.17
-7.09
-7.45
-4.10
Diluted EPS
-1.83
-3.17
-7.09
-7.45
-4.10
Basic Average Shares
35,028.1220
18,742.4940
8,835.5210
7,603.1600
5,583.0580
Diluted Average Shares
35,028.1220
18,742.4940
8,835.5210
7,603.1600
5,583.0580
Total Operating Income as Reported
-37,514.0000
-52,148.0000
-58,333.0000
-56,723.0000
-23,201.0000
Total Expenses
37,561.0000
52,251.0000
58,525.0000
56,991.0000
24,270.0000
Net Income from Continuing & Discontinued Operation
-46,468.0000
-51,847.0000
-62,624.0000
-56,670.0000
-23,081.0000
Normalized Income
-37,502.0000
-52,064.0000
-58,173.0000
-56,670.0000
-23,081.0000
Interest Income
12.0000
84.0000
160.0000
53.0000
120.0000
Net Interest Income
12.0000
84.0000
160.0000
53.0000
120.0000
EBIT
-37,514.0000
-52,148.0000
-58,333.0000
-56,723.0000
-23,201.0000
EBITDA
-37,514.0000
-52,148.0000
-58,333.0000
-56,723.0000
-23,201.0000
Net Income from Continuing Operation Net Minority Interest
-46,468.0000
-51,847.0000
-62,624.0000
-56,670.0000
-23,081.0000
Total Unusual Items Excluding Goodwill
-8,966.0000
217.0000
-4,451.0000
--
--
Total Unusual Items
-8,966.0000
217.0000
-4,451.0000
--
--
Normalized EBITDA
-28,548.0000
-52,365.0000
-53,882.0000
-56,723.0000
-23,201.0000
12/31/2020 - 12/19/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FBIO Fortress Biotech, Inc.
1.8500
-4.64%
TGTX TG Therapeutics, Inc.
34.40
+7.43%
LXRX Lexicon Pharmaceuticals, Inc.
0.7699
-4.99%
TNXP Tonix Pharmaceuticals Holding Corp.
0.5300
+120.37%
CRDF Cardiff Oncology, Inc.
4.0300
+2.81%
IBRX ImmunityBio, Inc.
3.0600
+6.62%
QURE uniQure N.V.
17.40
+12.99%
CMRX Chimerix, Inc.
2.9100
-1.36%
MGX Metagenomi, Inc.
3.1050
-4.17%
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.3000
-11.88%